Corestreet Logo

Jounce Therapeutics Inc (JNCE) Insider Trading

Total insider buys:
  • $10,187,139.99
Total insider sells:
  • $24,080,437.29
Most recent insider trade:
  • April 4, 2023
Most active insider trader:
  • Kimberlee C Drapkin
Trader NameDateTitleAmountPriceTypeTotal Value
April 4, 2023Director39,228$1.85Sell$72,571.80
March 13, 2023Major Shareholder65,701$0.99Buy$65,043.99
Jan. 9, 2023CEO20,191$1.10Sell$22,210.10
Jan. 9, 2023Insider4,159$1.10Sell$4,574.90
Jan. 9, 2023COO7,452$1.10Sell$8,197.20
Jan. 9, 2023CFO6,315$1.10Sell$6,946.50
Jan. 10, 2022Insider5,378$6.65Sell$35,763.70
Jan. 10, 2022CFO8,222$6.65Sell$54,676.30
Jan. 10, 2022CEO23,924$6.65Sell$159,094.60
Jan. 7, 2022CEO13,370$7.30Sell$97,601.00
Jan. 7, 2022CFO4,595$7.30Sell$33,543.50
Jan. 7, 2022Insider3,005$7.30Sell$21,936.50
Nov. 12, 2021Major Shareholder1,900,000$8.38Sell$15,922,000.00
May 25, 2021Major Shareholder552,520$8.00Sell$4,420,160.00
April 15, 2021Director200$10.00Sell$2,000.00
March 31, 2021Insider13,500$10.09Sell$136,215.00
March 15, 2021Director200$12.80Sell$2,560.00
Feb. 16, 2021Director200$11.78Sell$2,356.00
Jan. 22, 2021Insider18,000$11.95Sell$215,100.00
Jan. 21, 2021Director1,700$11.90Sell$20,230.00
Jan. 21, 2021CFO30,000$11.36Sell$340,800.00
Jan. 20, 2021Insider6,500$12.01Sell$78,065.00
Jan. 20, 2021CEO16,482$12.04Sell$198,443.28
Jan. 15, 2021CEO30,000$8.54Sell$256,200.00
Jan. 7, 2021CEO10,183$6.76Sell$68,837.08
Jan. 7, 2021CFO2,697$6.76Sell$18,231.72
Jan. 7, 2021Insider2,452$6.76Sell$16,575.52
Nov. 19, 2020Major Shareholder15,000$7.01Sell$105,150.00
Nov. 17, 2020Major Shareholder15,000$7.25Sell$108,750.00
Sept. 15, 2020Director10,000$10.00Sell$100,000.00
Sept. 1, 2020CFO7,200$8.06Sell$58,032.00
Aug. 18, 2020Insider744$4.71Sell$3,504.24
Aug. 17, 2020CFO454$4.86Sell$2,206.44
Aug. 14, 2020Insider1,728$4.67Sell$8,069.76
Aug. 14, 2020CFO984$4.64Sell$4,565.76
Jan. 7, 2020CFO2,624$7.78Sell$20,414.72
Jan. 7, 2020CEO7,150$7.78Sell$55,627.00
Jan. 6, 2020Director1,500$8.11Sell$12,165.00
Aug. 16, 2019Insider2,336$3.99Sell$9,320.64
Aug. 15, 2019CFO648$4.00Sell$2,592.00
Aug. 14, 2019Insider670$4.10Sell$2,747.00
June 15, 2018Insider1,900$7.84Buy$14,896.00
March 15, 2018Director2,000$28.11Sell$56,220.00
March 8, 2018CEO16,334$25.10Sell$409,983.40
March 8, 2018CFO5,267$25.01Sell$131,727.67
March 8, 2018Insider4,545$25.06Sell$113,897.70
March 5, 2018Insider4,545$21.50Sell$97,717.50
March 5, 2018CEO16,334$21.43Sell$350,037.62
March 5, 2018CFO5,267$21.42Sell$112,819.14
Jan. 26, 2018Director4,000$25.00Sell$100,000.00
First«1 of 2»Last

  • Insiders are both buying and selling Jounce Therapeutics Inc stock.

  • The insider traders at Jounce Therapeutics Inc are: Kimberlee C Drapkin, Richard /Ca/ Murray, Elizabeth Trehu, Hugh M Cole, John Duncan Higgons, Barbara Gayle Duncan, Rock Ventures Ii L.P. Third, Celgene Switzerland Llc, Rock Ventures Iii L.P. Third, and Kevin C Tang

  • The most active insider trader at Jounce Therapeutics Inc is Kimberlee C Drapkin with 12 trades.

  • Rock Ventures Iii L.P. Third has sold the most Jounce Therapeutics Inc stock with a total value of $31,844,000.00.

  • Celgene Switzerland Llc has bought the most Jounce Therapeutics Inc stock with a total value of $20,000,000.00.

  • The most recent insider trade for Jounce Therapeutics Inc was on April 4, 2023.

  • The single biggest insider buy for Jounce Therapeutics Inc was from Celgene Switzerland Llc with a total value of $10,000,000.00 on Feb. 1, 2017.

  • The single biggest insider sell for Jounce Therapeutics Inc was from Rock Ventures Iii L.P. Third with a total value of $15,922,000.00 on Nov. 12, 2021.